Assessment of a HER2 scoring system for colorectal cancer: results from a validation study
Modern Pathology2015Vol. 28(11), pp. 1481–1491
Citations Over TimeTop 10% of 2015 papers
Emanuele Valtorta, Cosimo Martino, Andrea Sartore‐Bianchi, Frédérique Penaullt-Llorca, Giuseppe Viale, Mauro Risio, Massimo Rugge, Francesco Grigioni, Katia Bencardino, Sara Lonardi, Vittorina Zagonel, Francesco Leone, Johannes Noé, Fortunato Ciardiello, Carmine Pinto, Roberto Labianca, Stefania Mosconi, Claudio Graiff, Giuseppe Aprile, Barbara Frau, Carlo Garufi, Fotios Loupakis, Patrizia Racca, Giuseppe Tonini, Calogero Lauricella, Silvio Veronese, Mauro Truini, Salvatore Siena, Silvia Marsoni, Marcello Gambacorta
Related Papers
- → Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab(2008)47 cited
- → Treatment with Panitumumab After a Severe Infusion Reaction to Cetuximab in a Patient with Metastatic Colorectal Cancer: A Case Report(2007)45 cited
- → Lapatinib: A competitor or companion to trastuzumab?(2009)8 cited
- → The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience(2020)2 cited
- → The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic(2017)